ALIMERA SCIENCES, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
ALIMERA SCIENCES, INC. had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $2.02 million as of 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2024-03-08
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.02M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.75M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.35M.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.90M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2023-12-31 | $2.02M 10-K · filed 2024-03-08 |
| 2022-12-31 | $2.75M 10-K · filed 2024-03-08 |
| 2021-12-31 | $3.35M 10-K · filed 2023-03-31 |
| 2020-12-31 | $4.90M 10-K · filed 2022-03-23 |
| 2019-12-31 | $4.77M 10-K · filed 2021-03-05 |
| 2018-12-31 | $4.49M 10-K · filed 2020-03-02 |
| 2017-12-31 | $3.69M 10-K · filed 2019-02-25 |
| 2016-12-31 | $4.66M 10-K · filed 2018-03-02 |